ACAD
ACADIA Pharmaceuticals Inc
Price:  
14.84 
USD
Volume:  
1,992,691.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Acadia Fair Value

-100.97 %
Upside

As of 2024-06-18, the Fair Value of ACADIA Pharmaceuticals Inc (ACAD) is -0.14 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 14.84 USD, the upside of ACADIA Pharmaceuticals Inc is -100.97%.

Note: valuation result may not be accurate due to the company's negative EPS.

14.84 USD
Stock Price
-0.14 USD
Fair Price
FAIR VALUE CALCULATION

Acadia Fair Value

Peter Lynch's formula is:

Acadia Fair Value
= Earnings Growth Rate x TTM EPS
Acadia Fair Value
= 13.54 x -0.01
Acadia Fair Value
= -0.14

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31 5Y Avg
Net income -235.30 -281.60 -167.90 -216.00 -61.29 -192.42
YoY growth 4.04% -19.68% 40.38% -28.65% 71.63% 13.54%

Acadia Fair Value - Key Data

Market Cap (mil) 2,451.86
P/E
Forward P/E
EPS -0.01
Avg earnings growth rate 13.54%
TTM earnings -1.75